Chest image staging and prevalence of current smoking among hospitalized
COVID-19 patients in Turkey
Abstract
Objective: Novel Coronavirus disease is a new infectious agent of the
respiratory tract characterized by a severe acute respiratory syndrome.
For this disease, there are limited data with regard to the clinical
characteristics of the patients and prognostic factors. Study Design:
Retrospective Cohort Setting: Secondary Referral Center Methods: We
collected data from 213 patients who were hospitalized into COVID-19
isolation with positive PCR test results. We recorded various patient
values, including blood test results. We also noted age, gender,
additional diseases, duration of discharge, whether they live or die,
whether they smoke, and their radiological staging. Results: In CT
imaging with a staging of maximum 4 points and minimum 0 points, the
mean value resulted in 1.95. The average radiological stage of the dead
patients group was reported as 2.56. There was a correlation between the
radiological predictor and the outcome status (p-value: 0.002). The
number of smokers was 14 (6.5%). Of the 26 patients who died, 3 were
smokers and 23 were non-smokers. Conclusion: 14 of the patients in the
study were smokers (6.5%). One in four people in Turkey is a smoker,
while in COVID-19 isolation service only a 6.5% rate of smoking was
observed. That supports the theory that smoking hasn’t negative impact
on COVID-19 development. The average radiological stage was reported as
2.56 in the dead patients’s group. There was a correlation between the
radiological predictor and the outcome status (p-value: 0.002). It seems
that an elevated radiological stage is a predictor of death. Keywords:
Covid-19, SARS-CoV-2, smoking, computed tomography, predictor factors.
Key points: to learn relations between smoking and covid-19, effect of
Ct stages on the disease severity, effect of blood analysis on Covid-19,
the parameters in deaths of Covid-19, ratio of smoking in Covid-19
inpatients